![](/img/cover-not-exists.png)
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
David M Reid, Jean-Pierre Devogelaer, Kenneth Saag, Christian Roux, Chak-Sing Lau, Jean-Yves Reginster, Philemon Papanastasiou, Alberto Ferreira, Florian Hartl, Taiwo Fashola, Peter Mesenbrink, PhilipVolume:
373
Year:
2009
Language:
english
DOI:
10.1016/s0140-6736(09)60250-6
File:
PDF, 211 KB
english, 2009